Cargando…

Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report

INTRODUCTION: Langerhans’ Cell Histiocytosis is a rare disease of unknown etiology, the pathogenesis of which involves both reactive and neoplastic processes. Despite potential resolution with conservative management, a rare recurrence in a distant site after 3 years from presentation in this case h...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Abdulsalam, Ali, Kapila, Kusum, Alherz, Mohammad, Alsayegh, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885459/
https://www.ncbi.nlm.nih.gov/pubmed/35242335
http://dx.doi.org/10.1016/j.amsu.2022.103401
_version_ 1784660425059598336
author Al Abdulsalam, Ali
Kapila, Kusum
Alherz, Mohammad
Alsayegh, Mohammad
author_facet Al Abdulsalam, Ali
Kapila, Kusum
Alherz, Mohammad
Alsayegh, Mohammad
author_sort Al Abdulsalam, Ali
collection PubMed
description INTRODUCTION: Langerhans’ Cell Histiocytosis is a rare disease of unknown etiology, the pathogenesis of which involves both reactive and neoplastic processes. Despite potential resolution with conservative management, a rare recurrence in a distant site after 3 years from presentation in this case highlights the variability in the course of the disease and the need for larger studies to enable recognition and evidence-based management. CASE PRESENTATION: We present an unusual case below of a 25-year-old gentleman who presented with sternal pain and tenderness. Imaging showed a lytic lesion in the sternum which resolved spontaneously with oral analgesia. He presented 3 years later with back pain and a similar lytic lesion in the iliac bone was found and diagnosed as recurrent Langerhans Cell Histiocytosis with a biopsy. CLINICAL DISCUSSION: There is a diverse array of documented presentations of Langerhans Cell Histiocytosis involving single or multiple systems, while its progression and outcomes are equally unpredictable from the current literature. In order to facilitate wider recognition, Langerhans Cell Histiocytosis should be considered in the differential diagnosis of recurrent lytic bone lesions. CONCLUSION: Although this is a rare disease, there is currently an unmet need for understanding the determinants of recurrence and response to treatment.
format Online
Article
Text
id pubmed-8885459
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88854592022-03-02 Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report Al Abdulsalam, Ali Kapila, Kusum Alherz, Mohammad Alsayegh, Mohammad Ann Med Surg (Lond) Case Report INTRODUCTION: Langerhans’ Cell Histiocytosis is a rare disease of unknown etiology, the pathogenesis of which involves both reactive and neoplastic processes. Despite potential resolution with conservative management, a rare recurrence in a distant site after 3 years from presentation in this case highlights the variability in the course of the disease and the need for larger studies to enable recognition and evidence-based management. CASE PRESENTATION: We present an unusual case below of a 25-year-old gentleman who presented with sternal pain and tenderness. Imaging showed a lytic lesion in the sternum which resolved spontaneously with oral analgesia. He presented 3 years later with back pain and a similar lytic lesion in the iliac bone was found and diagnosed as recurrent Langerhans Cell Histiocytosis with a biopsy. CLINICAL DISCUSSION: There is a diverse array of documented presentations of Langerhans Cell Histiocytosis involving single or multiple systems, while its progression and outcomes are equally unpredictable from the current literature. In order to facilitate wider recognition, Langerhans Cell Histiocytosis should be considered in the differential diagnosis of recurrent lytic bone lesions. CONCLUSION: Although this is a rare disease, there is currently an unmet need for understanding the determinants of recurrence and response to treatment. Elsevier 2022-02-24 /pmc/articles/PMC8885459/ /pubmed/35242335 http://dx.doi.org/10.1016/j.amsu.2022.103401 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Al Abdulsalam, Ali
Kapila, Kusum
Alherz, Mohammad
Alsayegh, Mohammad
Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report
title Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report
title_full Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report
title_fullStr Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report
title_full_unstemmed Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report
title_short Recurrence of a Langerhans Cell Histiocytosis bone lesion in a different site: A case report
title_sort recurrence of a langerhans cell histiocytosis bone lesion in a different site: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885459/
https://www.ncbi.nlm.nih.gov/pubmed/35242335
http://dx.doi.org/10.1016/j.amsu.2022.103401
work_keys_str_mv AT alabdulsalamali recurrenceofalangerhanscellhistiocytosisbonelesioninadifferentsiteacasereport
AT kapilakusum recurrenceofalangerhanscellhistiocytosisbonelesioninadifferentsiteacasereport
AT alherzmohammad recurrenceofalangerhanscellhistiocytosisbonelesioninadifferentsiteacasereport
AT alsayeghmohammad recurrenceofalangerhanscellhistiocytosisbonelesioninadifferentsiteacasereport